z-logo
open-access-imgOpen Access
Thomas MacLagan’s 1876 demonstration of the dramatic effects of salicin in rheumatic fever
Author(s) -
Derek Doyle
Publication year - 2014
Publication title -
journal of the royal society of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.38
H-Index - 81
eISSN - 1758-1095
pISSN - 0141-0768
DOI - 10.1177/0141076814540847
Subject(s) - salicin , rheumatic fever , medicine , biology , microbiology and biotechnology
It has been suggested without convincing documentation that people drank a potion of willow bark and chewed willow leaves to ease joint pains in the days of Hippocrates. What has been documented is that, in 1763, the Reverend Edmund Stone, a vicar in Chipping Norton, Oxfordshire, reported that a preparation he had made from dried willow bark was helpful in reducing fevers. Efforts to obtain a reliable extract of willow did not begin until the following century. In 1826, the Italians Brugnatelli and Fontana tried to produce a pure extract, and two years later Joseph Buchner, Professor of Pharmacy at Munich University, succeeded in producing bitter-tasting yellow crystals that he named ‘salicin’, after salix, the Latin name for willow. The formula of salicin is C13H18O7, and, in 1820, a French chemist, Henri Leroux, refined Buchner’s procedure and produced about 25 g of salicin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom